The Medical Research Council and treatments for tuberculosis before streptomycin.
نویسنده
چکیده
Despite being set up in 1913 using a fund specifically earmarked for tuberculosis, the Medical Research Committee (renamed the Medical Research Council [MRC] in 1919) prioritised other areas of medical research. From 1920, the MRC did have three subcommittees concerned with tuberculosis: the Tuberculin Committee, the Bacteriology Committee and the Occupational Phthisis (pulmonary tuberculosis) Committee (AS MacNalty, a medical officer in the Ministry of Health, was the secretary of all of them). However, none of these committees was primarily concerned with investigating the effects of the treatments in vogue in the 1920s and 1930s – sanatorium treatment, tuberculin, sanocrysin and artificial pneumothorax. The Council did provide some financial assistance to physicians researching treatments in institutional settings, but did little itself to evaluate the effects of these treatments.
منابع مشابه
The UK Medical Research Council and clinical trials, 1934-1960
1940-1949: Randomised controlled trial design pioneered MRC scientists developed what is today the gold standard for clinical trial design while testing streptomycin to treat pulmonary tuberculosis. Although the MRC failed to make any substantive contribution to the development of trial methods before the 1940s, it made exceptionally important contributions between 1944 and 1960. Surprisingly, ...
متن کاملComparison of solid and liquid medium sensitivity tests of tubercle bacilli to para-aminosalicylic acid.
In the treatment of tuberculosis para-aminosalicylic acid (P.A.S.) is now chiefly used in combination with streptomycin or isoniazid with the aim of preventing or delaying the emergence of drug-resistant strains of tubercle bacilli (Medical Research Council, 1950, 1953c). Such combined therapy is only effective in preventing drug resistance when the strains obtained before the start of treatmen...
متن کاملCommentary: the 1944 patulin trial: the first properly controlled multicentre trial conducted under the aegis of the British Medical Research Council.
The 1948 report of the British Medical Research Council's randomized trial of streptomycin for pulmonary tuberculosis is widely regarded as marking the beginning of the modern history of controlled clinical trials. Four years earlier, however, a methodologically sophisticated multicentre trial conducted under the aegis of the Medical Research Council was reported, which assessed the effects of ...
متن کاملOrigins of Combination Therapy for Tuberculosis: Lessons for Future Antimicrobial Development and Application
Tuberculosis is a global health problem that causes the death of approximately 1.5 million people worldwide each year (WHO, p. 1-126, Global Tuberculosis Report, 2015). Treatment of drug-susceptible tuberculosis requires combination antimicrobial therapy with a minimum of four antimicrobial agents applied over the course of 6 months. The first instance of combination antimicrobial therapy appli...
متن کاملComparison of techniques for measuring the isoniazid resistance of tubercle bacilli.
As with streptomycin and P.A.S., the introduction of isoniazid for the treatment of tuberculosis has raised the problem of the development of resistance to the drug in strains of tubercle bacilli recovered from treated patients. In the Medical Research Council (1952) trials 71% of cultures from patients who had received three months' treatment with isoniazid alone were found to be resistant. Al...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Journal of the Royal Society of Medicine
دوره 107 10 شماره
صفحات -
تاریخ انتشار 2014